News & Updates
Showing Multidisciplinary articles
Showing

Is it safe to use pyrazinamide in older patients with TB?
Adding pyrazinamide (PZA) to the initial tuberculosis (TB) treatment in older patients may lead to an increase in the incidence of adverse events (AEs), particularly allergic reactions, but not in-hospital mortality, length of hospital stay, or hepatotoxicity, reports a study, which used data from the Japanese Diagnosis Procedure Combination inpatient database.

Diabetes-related complications tied to higher risk of periodontitis
A study presented at EASD 2024 shows that microvascular complications of diabetes, such as diabetic neuropathy and retinopathy, are independently and concomitantly associated with moderate/severe periodontitis.

Benralizumab offers sustained remission in severe eosinophilic asthma
Treatment with benralizumab (BRZ) results in sustained remission in patients with severe eosinophilic asthma (SEA), particularly those with comorbid chronic rhinosinusitis with nasal polyps (CRSwNP) and reversible airflow limitation, reports a study.






